SCHEMBL714542

SCHEMBL714542

[CH]1c2cc(C3CCCCC3)ccc2-c2ccc(C3CCCCC3)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACMSD Q8TDX5 2/20 0.43
PDK2 Q15119 1/20 0.43
BACE1 P56817 1/20 0.42
EPHX2 P34913 1/20 0.41
KMO O15229 1/20 0.41
KMT2A Q03164 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
HSP90AA1 P07900 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
CYP3A4 P08684 2/20 0.38
HDAC4 P56524 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
CYP11B2 P19099 1/20 0.37
HTR1D P28221 1/20 0.36
HTT P42858 2/20 0.36
CYP2D6 P10635 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27862642 0.98 ACMSD (0.42) ACMSDPDK2BACE1EPHX2KMO
SCHEMBL27998355 0.93 PDK2 (0.39) ACMSDPDK2BACE1EPHX2KMO
SCHEMBL712935 0.83 ACMSD (0.43) ACMSDPDK2BACE1EPHX2KMO
SCHEMBL27862663 0.82 ACMSD (0.42) ACMSDPDK2BACE1EPHX2KMO
SCHEMBL27862640 0.79 ACMSD (0.40) ACMSDPDK2BACE1EPHX2KMO
SCHEMBL27998445 0.77 ACMSD (0.39) ACMSDPDK2BACE1EPHX2KMO
SCHEMBL7938786 0.75 EPHX2 (0.53) ACMSDPDK2BACE1EPHX2KMO
SCHEMBL28584923 0.74 HDAC8 (0.52) ACMSDKMT2ATDP1HSP90AA1GAA
SCHEMBL6275125 0.74 HDAC8 (0.52) ACMSDKMT2ATDP1HSP90AA1GAA
SCHEMBL42782 0.74 HDAC8 (0.52) ACMSDKMT2ATDP1HSP90AA1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8357765-B2 Process for producing catalyst component for addition polymerization SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-01-22 US disclosed
US-8288490-B2 Process for producing catalyst component for addition polymerization SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-16 US disclosed
US-20120053306-A1 PROCESS FOR PRODUCING CATALYST COMPONENT FOR ADDITION POLYMERIZATION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-01 US disclosed
US-20120053311-A1 PROCESS FOR PRODUCING CATALYST COMPONENT FOR ADDITION POLYMERIZATION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053306-A1 PROCESS FOR PRODUCING CATALYST COMPONENT FOR ADDITION POLYMERIZATION PPOX, SOD1, AP1M1 ACMSD 93/4885PDK2 553/4885BACE1 1427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.